Relationship of Dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus.
<h4>Objectives</h4>Dickkopf-1 (DKK1) is a potent inhibitor of Wnt signalling, which exerts anabolic effects on bone and also takes part in the regulation of vascular cells. Our aims were to evaluate serum DKK1 in type 2 diabetes (T2DM) patients and to analyze its relationships with cardi...
Guardado en:
Autores principales: | Antonia Garcia-Martín, Rebeca Reyes-Garcia, Beatriz García-Fontana, Sonia Morales-Santana, Ana Coto-Montes, Manuel Muñoz-Garach, Pedro Rozas-Moreno, Manuel Muñoz-Torres |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/644306ce613a4d35815a9402ce77a0e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1)
por: Shuang Gao, et al.
Publicado: (2021) -
The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population
por: Arnold Piek, et al.
Publicado: (2021) -
Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
por: Nick Hildebrandt, et al.
Publicado: (2021) -
Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
por: Mariusz L Hartman, et al.
Publicado: (2014) -
Elevated serum Dickkopf-1 is a biomarker for bone erosion in patients with psoriatic arthritis
por: Yukchiu Chung, et al.
Publicado: (2021)